Program#/Poster#: 233
Presentation Title:
PROSPECTIVE PLACEBO-CONTROLLED MULTICENTER TRIAL ON SAFETY AND EFFICACY OF PHYTOTHERAPY IN THE TREATMENT OF CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME
Presentation Time: 5/8/2004 4:40:00 PM
Author Block: Andreas Reissigl, Bob Djavan, Josef Pointner, Jurgen Brunner, Stefan Obwexer, Michael Marberger. lkh bregenz, Bregenz, Austria, univ vienna, Vienna, Austria
Introduction and Objective:
To evaluate the efficacy and safety endpoints in patients with
chronic prostatitis/chronic pelvic pain syndrome (cathegory III A/B CP/CPPS) treated with Serenoa repens.
Methods:
Men with Category IIIA/B chronic prostatitis / chronic pelvic pain syndrome were prospectively enrolled in 2 institutions and randomized to Permixon and matched with a placebo-control group. Both groups were comparable in terms of age, prostate volume and prostate-specific antigen (PSA). The response to therapy was evaluated at 6 and 12 weeks, 6 mo, 12mo and 18 mo after treatment based on efficacy parameters including Patients Subjective Global Assessment (SGA), the total NIH Chronic Prostatitis Symptom Index (CPSI), the pain, voiding and quality of life/impact domains of the CPSI, safety data, PSA and prostate volume.
Results:
142 patients were enrolled ( 72 Permixon; 70 control group).. By 12 and 18mo, 76.4% and 71,8%,in the active group (serenoa repens) had at least mild improvement (35-50% improvement) of the SGA and NIH-CPSI versus, 24,3 and 18,5 % in the control group. Furthermore, 55.7% and 52.6% reportet moderate or marked improvement (50% or greater improvement) versus 18.8% and 14,7%, respectively, of patients in the control group.
At 18 mo, 68,4%, 56,6% and 54.7% of patients in the active group demonstrated a 50% or greater improvement in IPSS, Qmax and QOL score, respectively, compared with 15.2%, 9.1% and 11,6%, respectively, in the control group. Overall, a 30% reduction of the NIH-CPSI score was observed in the active grooup versus 6.3% in the control group. Prostate volume did not change significantly in both groups. However, PSA decreased by 18% in the active group at 18 mo.whereas, PSA did not differ from Baseline in the control group.
Conclusions:
This multicenter study suggests that Permixon may provide clinical benefit in patients with Category IIIA/B CPPS. A moderate/marked improvement of the SGA and NIH-CPSI is observed in over 60% of patients. The decrease in serum PSA in CP/CPPS patients treated with Serenoa repens (not observed in men with BPH) suggests a different action pathway.
AUA 2004 - Permixon (Serenoa repens aka Saw Palmetto)
-
webslave
- Maintenance

- Posts: 11432
- Joined: Wed Oct 30, 2002 3:18 pm
- Location: Please give your location so we can help better
AUA 2004 - Permixon (Serenoa repens aka Saw Palmetto)
Good News! The great ProstaQ is BACK at last! You must try it.
| HAS THIS SITE HELPED YOU? Say Thanks by donating. Keep the Forum alive on the Internet! PayPal link at end of page ↓ Contact me at support at ucpps.men |
-
one day...
OK, so now, as our current thinking of chronic prostatitis / chronic pelvic pain syndrome is a muscle disorder, does this study suggest that it is the prostate that is causing the trouble? This seems to go along with DHT theory... Or does Saw Palmetto relax the muscles around our prostate? This study bothers me because I think it does not go along with my current protocol, and thinking. I have tried this herb, and it does work wonders for urinary function, but I stopped because it put my libido in the toilet.
-
webslave
- Maintenance

- Posts: 11432
- Joined: Wed Oct 30, 2002 3:18 pm
- Location: Please give your location so we can help better
Please read https://ucpps.men/pelvi ... pathy.html
Good News! The great ProstaQ is BACK at last! You must try it.
| HAS THIS SITE HELPED YOU? Say Thanks by donating. Keep the Forum alive on the Internet! PayPal link at end of page ↓ Contact me at support at ucpps.men |
-
scotsman
- Retired Mod

- Posts: 1415
- Joined: Mon Aug 18, 2003 4:26 pm
- Location: Scotland, UK
Excellent description Mark 
Not medical advice: Read my progress to date : Read about my W-A clinic visit
Age: 54 CPPS: 20 Yrs Recovery Status: 95% Symptoms: Pain around perineum Makes Worse: Tension, sitting Makes Better: Stretching, triggerpoint therapy, relaxation
Age: 54 CPPS: 20 Yrs Recovery Status: 95% Symptoms: Pain around perineum Makes Worse: Tension, sitting Makes Better: Stretching, triggerpoint therapy, relaxation
-
one day...
-
webslave
- Maintenance

- Posts: 11432
- Joined: Wed Oct 30, 2002 3:18 pm
- Location: Please give your location so we can help better
We are all so genetically different that yes, we should investigate until we find something that helps.
Good News! The great ProstaQ is BACK at last! You must try it.
| HAS THIS SITE HELPED YOU? Say Thanks by donating. Keep the Forum alive on the Internet! PayPal link at end of page ↓ Contact me at support at ucpps.men |
-
alphacentauri
Re: AUA 2004 - Permixon (Serenoa repens aka Saw Palmetto)
After reading the study, I've decided to give saw palmetto another try (I used it in the past). For the past 3-4 weeks, I've been using a supplement called 'Saw Palmetto and Pygeum Complex' from the Vitamin Shoppe. Each capsule contains 160mg of saw palmetto & 125mg of pygeum. It has other ingredients as well. I take 2 capsules a day.webslave wrote: PROSPECTIVE PLACEBO-CONTROLLED MULTICENTER TRIAL ON SAFETY AND EFFICACY OF PHYTOTHERAPY IN THE TREATMENT OF CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME
Has anyone tried this particular combination to any effect or has any comments on it?
BTW, I've never noticed any effects on libido from SP. And if anyone's using Quercetin, note that the new formula also contains SP, though they keep the exact amount a mystery.
